EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 310 full-time employees. The firm's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. The company specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. The company also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Mr. Ryan Rhodes is the Chief Executive Officer of Edap Tms SA, joining the firm since 2021.
What is the price performance of EDAP stock?
The current price of EDAP is $3.47, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Edap Tms SA?
Edap Tms SA belongs to Health Care industry and the sector is Health Care
What is Edap Tms SA market cap?
Edap Tms SA's current market cap is $130.0M
Is Edap Tms SA a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Edap Tms SA, including 2 strong buy, 4 buy, 3 hold, 0 sell, and 2 strong sell